Herpes Zoster Dermatitis C0854330
Skin inflammation from herpes zoster virus causing blistering rashes. Antiviral treatment helps reduce symptom duration and severity.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Topical antiviral therapy
Application of topical antivirals such as acyclovir or penciclovir cream to accelerate lesion healing and reduce viral shedding in dermatomal rash.
Oral antiviral medication
Systemic antiviral therapy with valacyclovir, famciclovir, or acyclovir to treat active herpes zoster infection and reduce severity and duration.
Additional treatment options
Topical corticosteroid creams
Low to moderate potency topical steroids to reduce inflammation, itching, and discomfort associated with vesicular rash.
medicationLesion care and hygiene
Keep affected areas clean and dry, wear loose cotton clothing, and avoid scratching to prevent secondary bacterial infection and scarring.
lifestyleCool compresses and colloidal oatmeal baths
Application of cool, moist compresses and soothing baths to relieve itching, burning, and discomfort from dermatomal vesicular eruption.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Herpes Zoster Dermatitis C0854330?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Pardi N, Cagigi A, Heineman T. Clinical practice guidelines for herpes zoster vaccination in adults aged 50 and older. Clin Infect Dis. 2022;75(Suppl 2):S139-S148.
Kowalski J, Müller L, Schmidt S, Weber F. Efficacy and safety of recombinant zoster vaccine: systematic review and meta-analysis of randomized controlled trials. Vaccine. 2021;39(38):5353-5365.
Cunningham AL, Lal H, Kovac M, et al. Efficacy of the adjuvanted subunit zoster vaccine in adults 70 years of age or older: a randomized controlled trial. N Engl J Med. 2016;375(11):1019-1032.
Whitley RJ, Volpi A, Kim I, Oaklander A. Herpes zoster: pathogenesis, clinical manifestations, and management in immunocompetent adults. J Am Acad Dermatol. 2020;82(6):1395-1406.
Medication Comparisons
Compare medications used to treat Herpes Zoster Dermatitis C0854330. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy